|
|
|
|
|
by jarrett
4517 days ago
|
|
> with or without the startup's consent I'm not convinced this is possible in the long run. The idea seems to be that employees can't sell the shares themselves, but can sell the kind of derivative around which Equidate is based. That may be true at the moment, in that the employees may not be contractually forbidden from writing such a derivative. But if companies currently forbid sales of the shares themselves, won't they eventually get wise and start to forbid sales of derivatives as well? |
|